Federal Trade Commission Returns Almost $515,000 to Consumers Who allegedly Bought Deceptively Marketed “Amniotic Stem Cell Therapy” Between 2014 and 2017 | site |









(April 30, 2019) - - Today, the Federal Trade Commission (FTC) published the following information: